Search

Your search keyword '"Pariente, Jérémie"' showing total 530 results

Search Constraints

Start Over You searched for: Author "Pariente, Jérémie" Remove constraint Author: "Pariente, Jérémie"
530 results on '"Pariente, Jérémie"'

Search Results

2. Robust thalamic nuclei segmentation from T1-weighted MRI

3. Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening

4. Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease

6. The long-term impact of irradiation on functional connectivity in brain circuits involved in memory processes after pediatric posterior fossa tumor

7. Translocator protein (TSPO) genotype does not change cerebrospinal fluid levels of glial activation, axonal and synaptic damage markers in early Alzheimer’s disease

10. Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression

15. Explaining the association between social and lifestyle factors and cognitive functions: a pathway analysis in the Memento cohort

16. The long-term impact of irradiation on functional connectivity in brain circuits involved in memory processes after pediatric posterior fossa tumor

17. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

20. Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial

21. Disfluency patterns in Alzheimer's disease and frontotemporal lobar degeneration.

23. Expressive Prosody in Patients With Focal Anterior Temporal Neurodegeneration

24. Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies

26. Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export.

30. Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort.

31. Clinical heterogeneity of neuro-inflammatory PET profiles in early Alzheimer’s disease

34. Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study

38. Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline

43. Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI)

44. Post-stroke remodeling processes in animal models and humans

47. Cerebral perfusion using ASL in patients with COVID-19 and neurological manifestations: A retrospective multicenter observational study

48. Cerebrospinal fluid YKL‐40 level evolution is associated with autoimmune encephalitis remission

49. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience

50. Huntington's Disease with Small CAG Repeat Expansions.

Catalog

Books, media, physical & digital resources